News
The ATA office will be closed Monday, September 6, 2021, in observance of the U.S. holiday Labor Day. We will reopen Tuesday, September 7, 2021, at 9 a.m. ET.
Read MoreDo you have Constant Tinnitus? (Ringing or Buzzing in the Ear) Title of Study: Validation and Expansion of Established Norms for Measures of Tinnitus Perception Study ID #4188 The National Center for Rehabilitative Auditory Research (NCRAR) at the VA Portland Health Care System is seeking individuals with constant tinnitus (ringing, humming, buzzing noise in the…
Read MoreThe American Tinnitus Association will be closed Monday, July 5, 2021, in obesrevance of Independence Day. Normal business hours will resume Tuesday, July 6.
Read MoreWe’re thrilled to announce that Tinnitus Today magazine and Conversations in Tinnitus podcast won four awards—two from EXCEL and two from Digital Health—which is a tremendous honor that underscores the importance of sharing the voices of people with tinnitus, such as yourselves, and those of researchers determined to put an end to tinnitus. “We’re incredibly grateful to our contributors,…
Read MoreThe American Tinnitus Association will be closed Friday, June 18, 2021, in obesrevance of Juneteenth. Normal business hours will resume Monday, June 21.
Read MoreThe American Tinnitus Association will be closed Monday, May 31, in honor of Memorial Day. Normal business hours will resume Tuesday, June 1.
Read MoreThe ATA Office will be closed in observance of President’s Day on Monday, February 15, 2021.
Read MoreThe ATA Office will be closed in observance of Christmas on December 25, 2020 and for New Years on January 1, 2021.
Read MoreThe ATA office will be closed for the Thanksgiving holiday starting Wednesday, November 25. We will reopen on Monday, November 30. 2020. Best wishes & Happy Thanksgiving to all!
Read MoreNeuromod has spent years conducting clinical trials to determine the efficacy of its Lenire bimodal stimulation device to reduce tinnitus symptoms. Results of the first of two large-scale clinical trials (TENT-A1), which included 326 participants across two European clinical sites (Dublin, Ireland and Regensburg, Germany), over a 15 months period, were released today. Note that…
Read More- « Previous
- 1
- 2
- 3
- 4
- Next »